Rohit Srivastava is a lecturer in the Department of Biosciences and Bioengineering at IIT Bombay specifying in medical diagnostic gadgets, nanoengineered resources, and photothermal cancer treatment.
Rajesh Gokhale Succeeds Renu Swarup as Department of Biotechnology Secretary science.thewire.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from science.thewire.in Daily Mail and Mail on Sunday newspapers.
Among the most intellectual immunologists,Kanury Rao also known as
Kanury Venkata Subba Rao has secured a special place. At ICGEB or the International Centre for Genetic Engineering and Biotechnology, he has worked as Senior Scientist and Head of the Immunology Group. This immunologist is known to be one of the reasons for the success of the Drug Discovery Research Centre, THSTI.
Immunology is a field in which Mr. Rao has made endless contributions. His research and work has helped in understanding the immune system better. In addition to this field, his contributions have been observed for molecular biology, drug discovery, cell, infectious disease biology, etc. It can be inferred that Mr. Rao is a man with extensive knowledge. His keen interest in immunology and the related fields is very much expressed by the quality of his contributions.
Share
New Delhi: The Department of Biotechnology (DBT) today celebrated its 35th Foundation Day. “The Department’s role in the fight against COVID-19 pandemic is commendable. A special grant of Rs. 900 crore under Atmanirbhar Bharat 3.0 has been allocated to the Department for the COVID-SURAKSHA towards development of vaccines against COVID-19”, speaker at the function pointed out.
The function to celebrate the 35th Foundation Day of DBT was held through video-conferencing.Speakers highlighted that the Department is making tremendous efforts to make our country Atmanirbhar in the Biotechnology sector. “National Biomedical Resource Indigenisation consortium (NBRIC) being the classical example”, he said. “This platform aims to achieve self-reliance towards diagnostics, vaccines and therapeutics for COVID-19 and beyond”, they added.